The interplay between micro RNAs and genetic liability to Alzheimer's Disease on memory trajectories in the general
Sandra Van der Auwera1, Linda Garvert2, Sabine Ameling3
1Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany; German Center for Neurodegenerative Diseases DZNE, Site Rostock/Greifswald, Greifswald, Germany.
Abstract:
Deficits in cognitive function and memory are common early symptoms of neurodegenerative disorders, such as Alzheimer's Disease (AD). Several studies have discussed micro RNAs (miRNAs) as potential epigenetic early detection biomarkers. In a longitudinal general population sample (n = 548) from the Study of Health in Pomerania, we analyzed the associations between 167 baseline miRNA levels and changes in verbal memory scores with a mean follow-up time of 7.4 years. We additionally assessed the impact of an individual's genetic liability for AD on verbal memory scores in n = 2,334 subjects and a possible interactions between epigenetic and genetic markers. Results revealed two miRNAs associated with changes in immediate verbal memory over time. In interaction analyses between miRNAs and a polygenic risk score for AD, five miRNAs showed a significant interaction effect on changes in verbal memory. All of these miRNAs have previously been identified in the context of AD, neurodegeneration or cognition. Our study provides candidate miRNAs for a decline in verbal memory as an early symptom of neurodegeneration and AD. Further experimental studies are needed to verify the diagnostic value of these miRNA markers in the prodromal stage of AD.
Insights
This study identifies specific microRNAs (miRNAs) linked to verbal memory decline, potentially serving as early biomarkers for neurodegenerative diseases like Alzheimer's Disease (AD). These findings highlight the interplay between genetic risk and epigenetic markers in cognitive health.
Area of Science:
- Neuroscience
- Genetics
- Epigenetics
Background:
- Cognitive deficits and memory loss are early indicators of neurodegenerative disorders, including Alzheimer's Disease (AD).
- MicroRNAs (miRNAs) are being investigated as potential epigenetic biomarkers for early disease detection.
- Understanding the relationship between genetic predisposition and epigenetic factors in cognitive decline is crucial.
Purpose of the Study:
- To investigate the association between baseline miRNA levels and longitudinal changes in verbal memory.
- To assess the impact of genetic liability for AD on verbal memory.
- To explore potential interactions between epigenetic (miRNA) and genetic markers in relation to verbal memory changes.
Main Methods:
- Analysis of 167 baseline miRNA levels in relation to verbal memory changes over a mean follow-up of 7.4 years in a general population sample (n=548).
- Assessment of the impact of a polygenic risk score for AD on verbal memory scores in a larger cohort (n=2,334).
- Statistical analysis to identify interactions between miRNA levels and genetic risk scores concerning verbal memory changes.
Main Results:
- Two miRNAs were significantly associated with changes in immediate verbal memory over time.
- Five miRNAs exhibited a significant interaction effect with a polygenic risk score for AD on verbal memory changes.
- The identified miRNAs have prior associations with AD, neurodegeneration, or cognitive function.
Conclusions:
- Candidate miRNAs have been identified that may serve as early indicators of verbal memory decline in neurodegeneration and AD.
- These findings suggest a potential role for specific miRNAs in the prodromal stages of AD.
- Further experimental research is warranted to validate the diagnostic utility of these miRNA biomarkers.
More Related Videos
Related Concept Videos
MicroRNAs
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...


